Literature DB >> 23501769

[Urachal cancers].

Charlotte Peugniez1, Tarek Ghoneim, Xavier Leroy, Eric Amela, Jean-Christophe Fantoni, Stéphane Culine, Arnauld Villers, Antoine Adenis.   

Abstract

Urachal cancer is a rare pathology (less than 1% among all bladder tumors) with a poor prognosis for all stages, because of clinical delay leading to a late diagnosis, difficult differential diagnosis with bladder cancer, and no consensus for the treatment, mostly about the chemotherapy for advanced stages, because there are no data from prospective studies. A surgical treatment can be performed for the localized stages, but there are no real guidelines for local relapses and metastatic progression treatment. Those cancers are not radio- or chemosensitive; nevertheless data from fundamental research are missing. As this pathology is really uncommon, there are no clinical studies with targeted therapies. The purpose of this review is to introduce the most important clinical and paraclinical features of those cancers, and the usual treatment performed.

Entities:  

Keywords:  chemotherapy; review; urachus

Mesh:

Year:  2013        PMID: 23501769     DOI: 10.1684/bdc.2013.1718

Source DB:  PubMed          Journal:  Bull Cancer        ISSN: 0007-4551            Impact factor:   1.276


  3 in total

1.  Management of urachal cancer: A consensus statement by the Canadian Urological Association and Genitourinary Medical Oncologists of Canada.

Authors:  Zineb Hamilou; Scott North; Christina Canil; Lori Wood; Sebastien Hotte; Srikala S Sridhar; Denis Soulières; Mathieu Latour; Daniel Taussky; Wassim Kassouf; Normand Blais
Journal:  Can Urol Assoc J       Date:  2019-07-23       Impact factor: 1.862

2.  U-shaped relationship of age at diagnosis and cancer-specific mortality in primary urachal adenocarcinoma: a cohort study.

Authors:  Dong-Dong Yu; Hui Dong; Zhi-Gang Wu; Yun-Bei Xiao; Chao-Feng Zhou; Qin-Quan Wang; Jian Cai
Journal:  Transl Androl Urol       Date:  2020-06

3.  Web-Based Prediction Models for Overall Survival and Cancer-Specific Survival of Patients With Primary Urachal Carcinoma: A Study Based on SEER Database.

Authors:  Li Ding; Bin Xia; Yang Zhang; Zijie Liu; Junqi Wang
Journal:  Front Public Health       Date:  2022-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.